6 days ago
1
Eoneren/E+ via Getty Images
Shares of atai Life Sciences (NASDAQ:ATAI) traded higher in the premarket on Tuesday after the company and its partner, Beckley Psytech Limited, said their jointly developed psychedelic drug BPL-003 succeeded in a mid-stage trial against depression.
Citing topline data from
English (US) ·